DAVIDE CAMPARI-MILANO NV (CPR.MI) Fundamental Analysis & Valuation
BIT:CPR • NL0015435975
Current stock price
6.3 EUR
+0.14 (+2.31%)
Last:
This CPR.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CPR.MI Profitability Analysis
1.1 Basic Checks
- In the past year CPR was profitable.
- CPR had a positive operating cash flow in the past year.
- CPR had positive earnings in each of the past 5 years.
- In the past 5 years CPR always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 4.27%, CPR is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
- With a Return On Equity value of 8.97%, CPR perfoms like the industry average, outperforming 46.43% of the companies in the same industry.
- With a decent Return On Invested Capital value of 6.57%, CPR is doing good in the industry, outperforming 60.71% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for CPR is in line with the industry average of 7.41%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 8.97% | ||
| ROIC | 6.57% |
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
1.3 Margins
- CPR's Profit Margin of 11.35% is fine compared to the rest of the industry. CPR outperforms 60.71% of its industry peers.
- In the last couple of years the Profit Margin of CPR has remained more or less at the same level.
- CPR has a better Operating Margin (19.74%) than 64.29% of its industry peers.
- In the last couple of years the Operating Margin of CPR has grown nicely.
- CPR has a better Gross Margin (60.31%) than 85.71% of its industry peers.
- In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.74% | ||
| PM (TTM) | 11.35% | ||
| GM | 60.31% |
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
2. CPR.MI Health Analysis
2.1 Basic Checks
- CPR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- CPR has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, CPR has more shares outstanding
- Compared to 1 year ago, CPR has an improved debt to assets ratio.
2.2 Solvency
- CPR has an Altman-Z score of 2.66. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.66, CPR belongs to the top of the industry, outperforming 82.14% of the companies in the same industry.
- CPR has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as CPR would need 6.60 years to pay back of all of its debts.
- CPR's Debt to FCF ratio of 6.60 is fine compared to the rest of the industry. CPR outperforms 67.86% of its industry peers.
- A Debt/Equity ratio of 0.59 indicates that CPR is somewhat dependend on debt financing.
- CPR's Debt to Equity ratio of 0.59 is fine compared to the rest of the industry. CPR outperforms 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 2.66 |
ROIC/WACC0.99
WACC6.61%
2.3 Liquidity
- CPR has a Current Ratio of 2.22. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
- CPR's Current ratio of 2.22 is fine compared to the rest of the industry. CPR outperforms 78.57% of its industry peers.
- CPR has a Quick Ratio of 2.22. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
- CPR has a Quick ratio of 0.96. This is in the better half of the industry: CPR outperforms 78.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 0.96 |
3. CPR.MI Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 66.22% over the past year.
- The Earnings Per Share has been growing by 12.04% on average over the past years. This is quite good.
- The Revenue has decreased by -0.60% in the past year.
- Measured over the past years, CPR shows a quite strong growth in Revenue. The Revenue has been growing by 11.48% on average per year.
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%
3.2 Future
- CPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.26% yearly.
- CPR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.37% yearly.
EPS Next Y4.41%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
EPS Next 5Y11.26%
Revenue Next Year0.52%
Revenue Next 2Y2.5%
Revenue Next 3Y3.34%
Revenue Next 5Y4.37%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. CPR.MI Valuation Analysis
4.1 Price/Earnings Ratio
- CPR is valuated rather expensively with a Price/Earnings ratio of 21.72.
- Based on the Price/Earnings ratio, CPR is valued a bit more expensive than the industry average as 60.71% of the companies are valued more cheaply.
- CPR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.77, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 19.99, the valuation of CPR can be described as rather expensive.
- Based on the Price/Forward Earnings ratio, CPR is valued a bit more expensive than 60.71% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 21.75. CPR is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.72 | ||
| Fwd PE | 19.99 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 64.29% of the companies listed in the same industry.
- 60.71% of the companies in the same industry are cheaper than CPR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.98 | ||
| EV/EBITDA | 12.78 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of CPR may justify a higher PE ratio.
PEG (NY)4.93
PEG (5Y)1.8
EPS Next 2Y8.37%
EPS Next 3Y9.02%
5. CPR.MI Dividend Analysis
5.1 Amount
- CPR has a Yearly Dividend Yield of 1.59%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 2.76, CPR is paying slightly less dividend.
- Compared to an average S&P500 Dividend Yield of 1.82, CPR has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.59% |
5.2 History
- The dividend of CPR decreases each year by -0.23%.
Dividend Growth(5Y)-0.23%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- CPR pays out 22.52% of its income as dividend. This is a sustainable payout ratio.
DP22.52%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
CPR.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:CPR (4/30/2026, 7:00:00 PM)
6.3
+0.14 (+2.31%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Industry Strength16.89
Industry Growth50
Earnings (Last)03-04 2026-03-04/amc
Earnings (Next)05-06 2026-05-06
Inst Owners21.27%
Inst Owner ChangeN/A
Ins Owners50.82%
Ins Owner ChangeN/A
Market Cap7.76B
Revenue(TTM)3.05B
Net Income(TTM)346.30M
Analysts73.33
Price Target7.3 (15.87%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.59% |
Yearly Dividend0.04
Dividend Growth(5Y)-0.23%
DP22.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.81%
PT rev (3m)3.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.73%
EPS NY rev (3m)-3.28%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.77%
Revenue NY rev (3m)-2.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.72 | ||
| Fwd PE | 19.99 | ||
| P/S | 2.54 | ||
| P/FCF | 19.98 | ||
| P/OCF | 11.28 | ||
| P/B | 2.01 | ||
| P/tB | 19.55 | ||
| EV/EBITDA | 12.78 |
EPS(TTM)0.29
EY4.6%
EPS(NY)0.32
Fwd EY5%
FCF(TTM)0.32
FCFY5.01%
OCF(TTM)0.56
OCFY8.86%
SpS2.48
BVpS3.14
TBVpS0.32
PEG (NY)4.93
PEG (5Y)1.8
Graham Number4.52368 (-28.2%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 8.97% | ||
| ROCE | 8.89% | ||
| ROIC | 6.57% | ||
| ROICexc | 7.34% | ||
| ROICexgc | 17.16% | ||
| OM | 19.74% | ||
| PM (TTM) | 11.35% | ||
| GM | 60.31% | ||
| FCFM | 12.73% |
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
ROICexc(3y)7.81%
ROICexc(5y)8.35%
ROICexgc(3y)19.64%
ROICexgc(5y)24.18%
ROCE(3y)9.45%
ROCE(5y)9.92%
ROICexgc growth 3Y-14.23%
ROICexgc growth 5Y-7.25%
ROICexc growth 3Y-6.36%
ROICexc growth 5Y1.27%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
F-Score8
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 3.02 | ||
| Cap/Depr | 201.82% | ||
| Cap/Sales | 9.81% | ||
| Interest Coverage | 6.43 | ||
| Cash Conversion | 91.62% | ||
| Profit Quality | 112.13% | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 2.66 |
F-Score8
WACC6.61%
ROIC/WACC0.99
Cap/Depr(3y)282.75%
Cap/Depr(5y)284.75%
Cap/Sales(3y)11.87%
Cap/Sales(5y)11.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
EPS Next Y4.41%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
EPS Next 5Y11.26%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%
Revenue Next Year0.52%
Revenue Next 2Y2.5%
Revenue Next 3Y3.34%
Revenue Next 5Y4.37%
EBIT growth 1Y1.65%
EBIT growth 3Y2.34%
EBIT growth 5Y14.68%
EBIT Next Year24.97%
EBIT Next 3Y12.76%
EBIT Next 5Y9.26%
FCF growth 1Y84.55%
FCF growth 3Y149.17%
FCF growth 5Y15.69%
OCF growth 1Y2.55%
OCF growth 3Y21.81%
OCF growth 5Y20.37%
DAVIDE CAMPARI-MILANO NV / CPR.MI Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?
ChartMill assigns a fundamental rating of 5 / 10 to CPR.MI.
What is the valuation status for CPR stock?
ChartMill assigns a valuation rating of 2 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.
How profitable is DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?
DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 7 / 10.
What is the valuation of DAVIDE CAMPARI-MILANO NV based on its PE and PB ratios?
The Price/Earnings (PE) ratio for DAVIDE CAMPARI-MILANO NV (CPR.MI) is 21.72 and the Price/Book (PB) ratio is 2.01.
Can you provide the expected EPS growth for CPR stock?
The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 4.41% in the next year.